The SPIREA Study is evaluating the safety and efficacy of an
investigational medication (a medication
not approved for clinical use) when used with standard-of-care medications for adults with active IIM.
The study will involve study clinic visits every 2 weeks over the course of up
to 112 weeks, or about 26 months.
About 200 participants will be enrolled, and they may be compensated for
study-required travel and expenses.
